Notice Number: NOT-AI-16-010

Key Dates
Release Date: November 24, 2015

Issued by
National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to update the following information in Key Dates in the funding opportunity announcement, RFA-AI-15-055, "B Cell Immunology Program for HIV-1 Vaccine Development (BCIP) (R01)" to reflect that all applications to this FOA are AIDS and AIDS-related applications:

Current Language:

Part 1. Overview Information

Key Dates

Application Due Date(s)
March 17, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)
March 17, 2016 by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on this date.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

New Language:
Application Due Date(s)
March 17, 2016 by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)
March 17, 2016 by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Angela Malaspina, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-292-6130
Email: amalaspina@niaid.nih.gov